SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis.

Megakaryopoiesis is a complex process that involves major cellular and nuclear changes and relies on controlled coordination of cellular proliferation and differentiation. These mechanisms are orchestrated in part by transcriptional regulators. The key hematopoietic transcription factor stem cell leukemia (SCL)/TAL1 is required in early hematopoietic progenitors for specification of the megakaryocytic lineage. These early functions have, so far, prevented full investigation of its role in megakaryocyte development in loss-of-function studies. Here, we report that SCL critically controls terminal megakaryocyte maturation. In vivo deletion of Scl specifically in the megakaryocytic lineage affects all key attributes of megakaryocyte progenitors (MkPs), namely, proliferation, ploidization, cytoplasmic maturation, and platelet release. Genome-wide expression analysis reveals increased expression of the cell-cycle regulator p21 in Scl-deleted MkPs. Importantly, p21 knockdown-mediated rescue of Scl-mutant MkPs shows full restoration of cell-cycle progression and partial rescue of the nuclear and cytoplasmic maturation defects. Therefore, SCL-mediated transcriptional control of p21 is essential for terminal maturation of MkPs. Our study provides a mechanistic link between a major hematopoietic transcriptional regulator, cell-cycle progression, and megakaryocytic differentiation.

[1]  Shamit Soneji,et al.  Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells. , 2010, Genome research.

[2]  S. Jane,et al.  The TAL1/SCL Transcription Factor Regulates Cell Cycle Progression and Proliferation in Differentiating Murine Bone Marrow Monocyte Precursors , 2010, Molecular and Cellular Biology.

[3]  G. Blobel,et al.  NuRD mediates activating and repressive functions of GATA‐1 and FOG‐1 during blood development , 2010, The EMBO journal.

[4]  A. Haman,et al.  Scl regulates the quiescence and the long-term competence of hematopoietic stem cells. , 2009, Blood.

[5]  J. Licht,et al.  Survivin is not required for the endomitotic cell cycle of megakaryocytes. , 2009, Blood.

[6]  S. Armstrong,et al.  Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis. , 2008, Blood.

[7]  R. Hardison,et al.  SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. , 2008, Blood.

[8]  P. Vyas,et al.  Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation. , 2008, Blood.

[9]  P. Vyas,et al.  Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis. , 2008, Blood.

[10]  D. Bluteau,et al.  P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1. , 2008, Blood.

[11]  N. Prévost,et al.  Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout. , 2008, Blood.

[12]  A. Goldfarb,et al.  Transcriptional control of megakaryocyte development , 2007, Oncogene.

[13]  J. Hartwig,et al.  Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis , 2007, Current opinion in hematology.

[14]  G. Kroemer,et al.  Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach. , 2007, Blood.

[15]  Anindya Dutta,et al.  Autocatalytic Phosphorylation of CDK2 at the Activating Thr160 , 2007, Cell cycle.

[16]  R. Shivdasani,et al.  Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2. , 2007, Blood.

[17]  R. Tiedt,et al.  Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. , 2007, Blood.

[18]  Mark A. Hall,et al.  A critical role for the transcription factor Scl in platelet production during stress thrombopoiesis. , 2006, Blood.

[19]  L. Cantley,et al.  Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis. , 2006, Blood.

[20]  W. Vainchenker,et al.  Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation. , 2006, Blood.

[21]  J. Hartwig,et al.  Cytoskeletal mechanisms for platelet production. , 2006, Blood cells, molecules & diseases.

[22]  T. Hoang,et al.  ETO2 coordinates cellular proliferation and differentiation during erythropoiesis , 2006, The EMBO journal.

[23]  E. Vellenga,et al.  Mammalian Target of Rapamycin Is Required for Thrombopoietin‐Induced Proliferation of Megakaryocyte Progenitors , 2006, Stem cells.

[24]  M. Weiss,et al.  Megakaryocyte biology and related disorders. , 2005, The Journal of clinical investigation.

[25]  P. Vyas,et al.  ETO-2 Associates with SCL in Erythroid Cells and Megakaryocytes and Provides Repressor Functions in Erythropoiesis , 2005, Molecular and Cellular Biology.

[26]  S. Orkin,et al.  Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)-dependent window during hematopoietic stem-cell development. , 2005, Blood.

[27]  A. Elefanty,et al.  SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development. , 2005, Blood.

[28]  M. Gering,et al.  Scl is required for dorsal aorta as well as blood formation in zebrafish embryos. , 2005, Blood.

[29]  T. Hoang,et al.  Translational control of SCL-isoform expression in hematopoietic lineage choice. , 2003, Genes & development.

[30]  S. Orkin,et al.  Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene , 2003, Nature.

[31]  Donald Metcalf,et al.  The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. Pflumio,et al.  Maximal lentivirus-mediated gene transfer and sustained transgene expression in human hematopoietic primitive cells and their progeny. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  J. Blenis,et al.  Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. , 2002, Genes & development.

[34]  W. Vainchenker,et al.  Role of p21(Cip1/Waf1) in cell-cycle exit of endomitotic megakaryocytes. , 2001, Blood.

[35]  P. Charneau,et al.  Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  T. P. Neufeld,et al.  Regulation of cellular growth by the Drosophila target of rapamycin dTOR. , 2000, Genes & development.

[37]  L. Zon,et al.  Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. , 1999, Development.

[38]  J. Dick,et al.  Enhanced Megakaryocyte and Erythroid Development From Normal Human CD34+ Cells: Consequence of Enforced Expression of SCL , 1998 .

[39]  G. Condorelli,et al.  Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. , 1998, Cancer research.

[40]  K. Ravid,et al.  A role for cyclin D3 in the endomitotic cell cycle , 1997, Molecular and cellular biology.

[41]  W. Vainchenker,et al.  Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. , 1997, Blood.

[42]  C. Begley,et al.  Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Orkin,et al.  Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL , 1995, Nature.

[44]  J. Li,et al.  Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. , 1994, The EMBO journal.

[45]  J. Li,et al.  The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Francesca Chiaromonte,et al.  Erythroid GATA 1 function revealed by genome-wide analysis of transcription factor occupancy , histone modifications , and mRNA expression , 2009 .

[47]  S. Orkin,et al.  Consequences of GATA-1 deficiency in megakaryocytes and platelets. , 1999, Blood.

[48]  J. Dick,et al.  Enhanced megakaryocyte and erythroid development from normal human CD34(+) cells: consequence of enforced expression of SCL. , 1998, Blood.